CTI BioPharma Stock Price (NASDAQ:CTIC)

Add to My Stocks
$3.41 $0.12 (3.4%) CTIC stock closing price Jul 21, 2017 (Closing)
Prev Close* : $3.53
Market Cap:
Day Low: $3.33
52 Week Low: $2.70
Open: $3.51
Volume: 215709
Day High: $3.54
52 Week High: $6.48

Latest Stock Market News

Latest Articles

CTI BioPharma News - From Partners

CTIC Stockcharts

View CTIC PE ratio, PS ratio stocks charts and compare with peers.
CTIC Chart
Note: Compare CTI BioPharma stock price history with the index and industry peers.

CTI BioPharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

CTI BioPharma Financial Ratios

Asset Turnover
Receivables Turnover

CTIC Industry Peers

Company Price Change (%)
Elite Pharma (ELTP)0.120 (0%)
Acelrx Pharma (ACRX)3.150.05 (1.61%)
Baxalta (BXLT)46.020.18 (0.39%)
Dare Bioscience (DARE)5.261.3 (19.82%)
Ambit Biosciences (AMBI)15.60 (0%)
Teva Pharmaceutical (TEVA)32.640.21 (0.65%)
Incyte (INCY)134.220.43 (0.32%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
ImmunoGen (IMGN)5.660.24 (4.07%)
CTI BioPharma (CTIC)3.410.12 (3.4%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 22, 2017

CTI BioPharma Corp Stock News - Partner Headlines

CTI BioPharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues57.4M16.11M60.07M34.67M-
Net Income-52M-119.42M-93.36M-42.74M-101.37M
Total Operating Expense105.18M130.83M145.41M76.06M101.48M
view CTI BioPharma Corp income statement
balance sheet20162015201420132012
Total Assets63.84M144.33M92.28M93.72M73.71M
Total Liabilities56.08M96.91M52.36M37.5M27.3M
Shareholders Equity7.75M47.41M39.92M56.21M46.4M
view CTI BioPharma Corp balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-8.57M7.45M9.68M-3.79M2.91M
Net Cash From (Used By) Operating Activities-76.68M-95.2M-39.55M-35.83M-62.77M
Increase (Decrease) In Prop Plant And Equipment-0.13M-0.07M-0.33M-1.53M-2.93M
view CTI BioPharma Corp cashflow statement

CTI BioPharma Stock Message Board

As of last trading day, CTI BioPharma stock price was 3.41. Looking at CTI BioPharma market capitalization, which currently stands at 100.21M, we can say that CTIC stock is a Micro cap stock. CTI BioPharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that CTI BioPharma is worth a lot, it will most likely be reflected in an inflated CTI BioPharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 215709 shares were traded with a closing stock price of 3.41 as of 21 Jul, 2017, as can be seen from CTI BioPharma stock quote. One can view CTI BioPharma stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. CTI BioPharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.